|
ETHICON INC. SFX SPI PDS+ UNI VIO 27IN 2-0 S/A SH; SUTURE, SURGICAL, ABSORBABLE, POLYDIOXANONE
|
Back to Search Results |
|
| Model Number |
SXPP1B417 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Wound Dehiscence (1154)
|
| Date of Event |
12/01/2020
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
(b)(4).To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.The patient demographic info: age, gender, weight, bmi at the time of index procedure date and name of the surgical procedure.The diagnosis and indication for the index surgical procedure.On what tissue was the suture placed? what was the tissue condition, i.E., normal or thin, calcified, fragile, diseased? was the fixation loop secured to tissue at the initiation of suture use during the index procedure? was at least one reverse stitch performed prior to closure? what date did the patient present with dehiscence (# of post-op days)? what tissue dehisced? how was the dehiscence managed? was surgical intervention performed for the dehiscence? if yes, please describe the intervention and date of intervention.Was medical intervention provided to the patient for the dehiscence? if yes, please describe.What was the appearance of the suture when the dehiscence occurred? was there any precipitating stress factor for the suture pulling out the of the tissue? other relevant patient history/concomitant medications.Lot number.What is the physician¿s opinion as to the etiology of or contributing factors to this event? what is the patient¿s current status? note: events reported via mw# 2210968-2021-00126.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
| |
|
Event or Problem Description
|
|
It was reported that the patient underwent reduction or reconstructive procedure on an unknown date and suture was used.Post-op the patient experienced dehiscence.It was reported that the patient current status is fine.Additional information has been requested.
|
| |
|
Additional Manufacturer Narrative
|
|
(b)(4) date sent to the fda: 2/4/2021 additional information: a1, d4, e1, e3, g2, h4, h6 additional h6 component code: g07002 ¿ device not returned a manufacturing record evaluation was performed for the finished device batch qebdqr, sxpp1b417 and no non-conformances were identified.Additional information was requested and the following was obtained: -on what tissue was the suture placed? breast tissue (deep dermal) -what was the tissue condition, i.E., normal or thin, calcified, fragile, diseased? normal -lot numbers (qebdqr),( qcbexm) -was at least one reverse stitch performed prior to closure? yes -what date did the patient present with dehiscence (# of post-op days)? within 7 days -patient doing well.This report is being submitted pursuant to the provisions of 21 cfr, part 803 and part 4.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
| |
|
Search Alerts/Recalls
|
|
|